ID   ATF2_RAT                Reviewed;         487 AA.
AC   Q00969; Q62870;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   24-JUL-2024, entry version 181.
DE   RecName: Full=Cyclic AMP-dependent transcription factor ATF-2;
DE            Short=cAMP-dependent transcription factor ATF-2;
DE   AltName: Full=Activating transcription factor 2;
DE   AltName: Full=cAMP response element-binding protein CRE-BP1;
GN   Name=Atf2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=1714459; DOI=10.1016/s0021-9258(18)98648-5;
RA   Kageyama R., Sasai Y., Nakanishi S.;
RT   "Molecular characterization of transcription factors that bind to the cAMP
RT   responsive region of the substance P precursor gene. cDNA cloning of a
RT   novel C/EBP-related factor.";
RL   J. Biol. Chem. 266:15525-15531(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Muramatsu S.;
RL   Submitted (OCT-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53 AND SER-94, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional activator which regulates the transcription
CC       of various genes, including those involved in anti-apoptosis, cell
CC       growth, and DNA damage response. Dependent on its binding partner,
CC       binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-
CC       3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-
CC       3'). In the nucleus, contributes to global transcription and the DNA
CC       damage response, in addition to specific transcriptional activities
CC       that are related to cell development, proliferation and death. In the
CC       cytoplasm, interacts with and perturbs HK1- and VDAC1-containing
CC       complexes at the mitochondrial outer membrane, thereby impairing
CC       mitochondrial membrane potential, inducing mitochondrial leakage and
CC       promoting cell death. The phosphorylated form (mediated by ATM) plays a
CC       role in the DNA damage response and is involved in the ionizing
CC       radiation (IR)-induced S phase checkpoint control and in the
CC       recruitment of the MRN complex into the IR-induced foci (IRIF).
CC       Exhibits histone acetyltransferase (HAT) activity which specifically
CC       acetylates histones H2B and H4 in vitro. In concert with CUL3 and RBX1,
CC       promotes the degradation of KAT5 thereby attenuating its ability to
CC       acetylate and activate ATM. Can elicit oncogenic or tumor suppressor
CC       activities depending on the tissue or cell type (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds DNA as a dimer and can form a homodimer in the absence
CC       of DNA. Can form a heterodimer with JUN. Heterodimerization is
CC       essential for its transcriptional activity. Interacts with SMAD3 and
CC       SMAD4. Binds through its N-terminal region to UTF1 which acts as a
CC       coactivator of ATF2 transcriptional activity (By similarity). Interacts
CC       with the HK1/VDAC1 complex. Interacts with NBN, MRE11, XPO1, KAT5 and
CC       CUL3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}. Mitochondrion
CC       outer membrane {ECO:0000250}. Note=Shuttles between the cytoplasm and
CC       the nucleus and heterodimerization with JUN is essential for the
CC       nuclear localization. Localization to the cytoplasm is observed under
CC       conditions of cellular stress and in disease states. Localizes at the
CC       mitochondrial outer membrane in response to genotoxic stress.
CC       Phosphorylation at Thr-34 is required for its nuclear localization and
CC       negatively regulates its mitochondrial localization. Colocalizes with
CC       the MRN complex in the IR-induced foci (IRIF) (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00969-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00969-2; Sequence=VSP_000591;
CC   -!- PTM: Phosphorylation of Thr-51 by MAPK14 and MAPK11, and at Thr-53 by
CC       MAPK1/ERK2, MAPK3/ERK1, MAPK11, MAPK12 and MAPK14 in response to
CC       external stimulus like insulin causes increased transcriptional
CC       activity. Phosphorylated by PLK3 following hyperosmotic stress. Also
CC       phosphorylated and activated by JNK and CaMK4. ATM-mediated
CC       phosphorylation at Ser-472 and Ser-480 stimulates its function in DNA
CC       damage response. Phosphorylation at Ser-44, Thr-55 and Ser-103
CC       activates its transcriptional activity. Phosphorylation at Thr-51 or
CC       Thr-53 enhances acetylation of histones H2B and H4.
CC       {ECO:0000250|UniProtKB:P15336}.
CC   -!- SIMILARITY: Belongs to the bZIP family. ATF subfamily. {ECO:0000305}.
CC   -!- CAUTION: Appears to have histone acetyltransferase (HAT) activity,
CC       specifically towards histones H2B and H4 in vitro (By similarity).
CC       However, it is not clear if this activity is genuine or caused by
CC       contamination with other histone acetyltransferases in the assay.
CC       {ECO:0000250|UniProtKB:P15336, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M65148; AAA42013.1; -; mRNA.
DR   EMBL; U38938; AAA93263.1; -; mRNA.
DR   PIR; A39429; A39429.
DR   RefSeq; NP_112280.1; NM_031018.1. [Q00969-1]
DR   AlphaFoldDB; Q00969; -.
DR   BMRB; Q00969; -.
DR   SMR; Q00969; -.
DR   BioGRID; 249547; 3.
DR   CORUM; Q00969; -.
DR   STRING; 10116.ENSRNOP00000002174; -.
DR   GlyGen; Q00969; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q00969; -.
DR   PhosphoSitePlus; Q00969; -.
DR   PaxDb; 10116-ENSRNOP00000002174; -.
DR   Ensembl; ENSRNOT00000050513.5; ENSRNOP00000046001.3; ENSRNOG00000001597.9. [Q00969-2]
DR   Ensembl; ENSRNOT00055040097; ENSRNOP00055032544; ENSRNOG00055023318. [Q00969-1]
DR   Ensembl; ENSRNOT00060026385; ENSRNOP00060021106; ENSRNOG00060015350. [Q00969-1]
DR   Ensembl; ENSRNOT00065029334; ENSRNOP00065023280; ENSRNOG00065017506. [Q00969-1]
DR   GeneID; 81647; -.
DR   KEGG; rno:81647; -.
DR   UCSC; RGD:621862; rat. [Q00969-1]
DR   AGR; RGD:621862; -.
DR   CTD; 1386; -.
DR   RGD; 621862; Atf2.
DR   VEuPathDB; HostDB:ENSRNOG00000001597; -.
DR   eggNOG; KOG1414; Eukaryota.
DR   GeneTree; ENSGT00940000156582; -.
DR   HOGENOM; CLU_021564_0_0_1; -.
DR   InParanoid; Q00969; -.
DR   OrthoDB; 1361169at2759; -.
DR   PhylomeDB; Q00969; -.
DR   Reactome; R-RNO-3214847; HATs acetylate histones.
DR   Reactome; R-RNO-450341; Activation of the AP-1 family of transcription factors.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   PRO; PR:Q00969; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000001597; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0016602; C:CCAAT-binding factor complex; IDA:MGI.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:1902562; C:H4 histone acetyltransferase complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0035861; C:site of double-strand break; ISS:UniProtKB.
DR   GO; GO:0035497; F:cAMP response element binding; IDA:RGD.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0044013; F:histone H2B acetyltransferase activity; ISO:RGD.
DR   GO; GO:0010485; F:histone H4 acetyltransferase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043522; F:leucine zipper domain binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0021742; P:abducens nucleus development; ISO:RGD.
DR   GO; GO:0060612; P:adipose tissue development; ISO:RGD.
DR   GO; GO:0097186; P:amelogenesis; IDA:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:1902742; P:apoptotic process involved in development; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0003360; P:brainstem development; ISO:RGD.
DR   GO; GO:0044255; P:cellular lipid metabolic process; ISO:RGD.
DR   GO; GO:0072740; P:cellular response to anisomycin; ISO:RGD.
DR   GO; GO:1990253; P:cellular response to leucine starvation; ISO:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0098586; P:cellular response to virus; ISO:RGD.
DR   GO; GO:0060245; P:detection of cell density; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0021754; P:facial nucleus development; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0003418; P:growth plate cartilage chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0003419; P:growth plate cartilage chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.
DR   GO; GO:0021743; P:hypoglossal nucleus development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:1990144; P:intrinsic apoptotic signaling pathway in response to hypoxia; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0031573; P:mitotic intra-S DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0097049; P:motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0060052; P:neurofilament cytoskeleton organization; ISO:RGD.
DR   GO; GO:0001865; P:NK T cell differentiation; ISO:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0038066; P:p38MAPK cascade; ISO:RGD.
DR   GO; GO:0110024; P:positive regulation of cardiac muscle myoblast proliferation; ISO:RGD.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1902110; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0032915; P:positive regulation of transforming growth factor beta2 production; ISO:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0006970; P:response to osmotic stress; ISS:UniProtKB.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISO:RGD.
DR   GO; GO:0007033; P:vacuole organization; ISO:RGD.
DR   GO; GO:0050872; P:white fat cell differentiation; ISO:RGD.
DR   CDD; cd14687; bZIP_ATF2; 1.
DR   CDD; cd12192; GCN4_cent; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR051027; bZIP_transcription_factors.
DR   InterPro; IPR016378; TF_CRE-BP1-typ.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR19304:SF9; CYCLIC AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-2; 1.
DR   PANTHER; PTHR19304; CYCLIC-AMP RESPONSE ELEMENT BINDING PROTEIN; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PIRSF; PIRSF003153; ATF2_CRE-BP1; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Cytoplasm; DNA damage;
KW   DNA-binding; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion outer membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..487
FT                   /note="Cyclic AMP-dependent transcription factor ATF-2"
FT                   /id="PRO_0000076579"
FT   DOMAIN          334..397
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   ZN_FING         7..31
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          107..130
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          241..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          278..281
FT                   /note="Essential for its histone acetyltransferase
FT                   activity"
FT                   /evidence="ECO:0000250"
FT   REGION          336..356
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          362..390
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          407..487
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           387..396
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        288..324
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        325..348
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        424..487
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         34
FT                   /note="Phosphothreonine; by PKC/PRKCH"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         44
FT                   /note="Phosphoserine; by VRK1"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         51
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         53
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         55
FT                   /note="Phosphothreonine; by VRK1"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         94
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         98
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         103
FT                   /note="Phosphoserine; by PKC/PRKCA and PKC/PRKCB"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         118
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         322
FT                   /note="Phosphoserine; by PKC/PRKCA and PKC/PRKCB"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         339
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         349
FT                   /note="Phosphoserine; by PKC/PRKCA and PKC/PRKCB"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         356
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         428
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         472
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   MOD_RES         480
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000250|UniProtKB:P15336"
FT   VAR_SEQ         132..229
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1714459"
FT                   /id="VSP_000591"
SQ   SEQUENCE   487 AA;  52287 MW;  4ED95B106DF5F9EE CRC64;
     MSDDKPFLCT APGCGQRFTN EDHLAVHKHK HEMTLKFGPA RNDSVIVADQ TPTPTRFLKN
     CEEVGLFNEL ASPFENEFKK ASEDDIKKMP LDLSPLATPI IRSKIEEPSV VETTHQDSPL
     PHPESTTNDE KEIPLAQTAQ PTSAIVRPAS LQVPNVLLTS SDSSVIIQQA VPSPTSSTVI
     TQAPSSNRPI VPVPGPFPLL LHLPNGQTMP VAIPASITSS NVHVPAAVPL VRPVTMVPSV
     PGIPGPSSPQ PVQSEAKMRL KAALTQQHPP VTNGDTVKGH GSGLVRAQSE ESRPQSLQQP
     ATSTTETPAS PAHTTPQTQN TSGRRRRAAN EDPDEKRRKF LERNRAAASR CRQKRKVWVQ
     SLEKKAEDLS SLNGQLQSEV TLLRNEVAQL KQLLLAHKDC PVTAMQKKSG YHTADKDDSS
     EDLSVPSSPH TEAIQHSSVS TSNGVSSTSK TEAGATSVLT QMADQSTEPA LSQIVMAPSS
     QAQPSGS
//
